A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...
During last night's game presented by Emory Healthcare, the Atlanta Hawks Foundation, together with the Ressler Gertz Family Foundation, announced a $150,000 donation to the Prostate Cancer Foundation ...
The Prostate Cancer Foundation (PCF) today announced a $10 million unrestricted gift from an anonymous donor to launch a TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Award, which will ...
In 2026, an estimated 158,850 new cases of colorectal cancer (CRC) will be diagnosed, and 55,230 people will die from the disease in the United States. The Alaska Native population has the highest CRC ...
In 2025, adults aged 25-34 FAIR Health Consumer, while adults 65 and older (the largest user group in 2024) remained a high proportion of users. FAIR Health Consumer (fairhealthconsumer.org) is FAIR ...
Northern Arizona Healthcare announces “Meet Our Experts Live,” featuring NAH physicians educating community members about ...
The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...
Survey findings highlight need for improved education and access to precision medicine in the Japanese American ...
The city says it will devote $2 million to improve health outcomes, including for Black men in particular, who have Boston’s lowest life expectancy.
The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of JUF, and is supported in part by the Michael Reese Health Trust.
Cells rely on biomolecular condensates to coordinate essential biological processes without surrounding membranes. These droplet-like dynamic assemblies control the way in which DNA is turned into ...
Easier than a blood test, saliva tests have the potential to detect cavities, infections and even cancer. But a lack of insurance coverage and other obstacles stand in the way of wider use.